UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000031720
Receipt number R000036227
Scientific Title Evaluation of peripheral nerve function during reverse total shoulder arthroplasty using motor-evoked potentials
Date of disclosure of the study information 2018/03/15
Last modified on 2020/03/15 10:43:43

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of peripheral nerve function during reverse total shoulder arthroplasty using motor-evoked potentials

Acronym

Evaluation of peripheral nerve function during reverse total shoulder arthroplasty using motor-evoked potentials

Scientific Title

Evaluation of peripheral nerve function during reverse total shoulder arthroplasty using motor-evoked potentials

Scientific Title:Acronym

Evaluation of peripheral nerve function during reverse total shoulder arthroplasty using motor-evoked potentials

Region

Japan


Condition

Condition

Patients met the guidelines for reverse total shoulder arthroplasty made by the Japanese Orthopaedic Association

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of the present study was to compare the incidence and patterns of intraoperative nerve injury between deltopectoral and anterosuperior surgical approaches performing the revese total shoulder arthroplasty, and to detect the predisposing factors of nerve injury.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Amplitude attenuation and prolongation of latency in motor-evoked potentials.

Key secondary outcomes

Functional evaluation of the shoulder was performed with the UCLA score and Constant-Murley shoulder outcome score and self-reporting scale(Simple Shoulder test) .The scores obtained preoperative and 6-, 12-,24-months after the operation


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Maneuver

Interventions/Control_1

Reverse total shoulder arthroplasty via deltopectoral approach using motor-evoked potentials.

Interventions/Control_2

Reverse total shoulder arthroplasty via anterosuperior approach using motor-evoked potentials.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

70 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients met the guidelines for reverse total shoulder arthroplasty(RTSA) indications made by the Japanese Orthopaedic Association undergoing the primary RTSA.

Key exclusion criteria

Patients who had history of brain trauma,previous surgery to the spine.
Patiens in whom electrophysiological examination was impossible because of permanent neuropathy around the shoulder.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Terufumi
Middle name
Last name Shibata

Organization

Fukuoka University Faculty of Medicine

Division name

Dept.of Orthop.Surg

Zip code

814-0180

Address

7-45-1 Nanakuma, Jonan-ku,Fukuoka, Japan

TEL

092-801-1011

Email

teru-sky-ideal@lion.ocn.ne.jp


Public contact

Name of contact person

1st name Terufumi
Middle name
Last name Shibata

Organization

Fukuoka University Faculty of Medicine

Division name

Dept.of Orthop.Surg

Zip code

814-0180

Address

7-45-1 Nanakuma, Jonan-ku,Fukuoka, Japan

TEL

092-801-1011

Homepage URL


Email

teru-sky-ideal@lion.ocn.ne.jp


Sponsor or person

Institute

Fukuoka University Faculty of Medicine
Dept.of Orthop.Surg

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Fukuoka University - Medical Ethics Review Board

Address

7-45-1 Nanakuma, Jonan-ku,Fukuoka, Japan

Tel

092-801-1011

Email

fumed-ethics@fukuoka-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 03 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 02 Month 02 Day

Date of IRB

2017 Year 02 Month 02 Day

Anticipated trial start date

2017 Year 04 Month 03 Day

Last follow-up date

2020 Year 02 Month 03 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 03 Month 14 Day

Last modified on

2020 Year 03 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036227


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name